British American Tobacco p.l.c. (BATS) Earnings Call Transcript & Summary

July 26, 2023

London Stock Exchange GB Consumer Staples Tobacco earnings 67 min

Earnings Call Speaker Segments

Tadeu Marroco

executive
#1

Good morning, everyone. I'm Tadeu Marroco, and as BAT's Chief Executive, I'm delighted to welcome all of you to the presentation of our half-year results. Joining me this morning is Javed Iqbal, our Interim Finance Director. After we've finished the presentation, Victoria Buxton, who serves as our Group Head of Investor Relations, will come up on stage so we can field your questions, whether by phone or via the webcast facility. I'll start by covering the financial highlights for the half year, the progress being made in our transformation, and the main areas I intend to focus on as Chief Executive. Javed will then walk you through our financial performance in greater detail. On that basis, I'll assume you've all reviewed the disclaimers on slides two and three. I'm pleased with the way BAT has performed during the first half of this year, delivering growth in revenue, profit from operations, and earnings per share. Our reported results reflect the impact of one-off items in the prior period, including impairment of our business in Russia and Belarus, the U.S. DOJ OFAC provision, restructuring charges relating to Quantum, and positive FX tailwinds. From here, we'll focus on constant currency-adjusted results, unless otherwise stated. The breadth and the scale of our global footprint stand out as one of our company's important strengths, enabling us to consistently deliver balanced and sustainable results.

Tadeu Marroco

executive
#2

During the first half, that's shown by how well we did in AME and APMEA, which more than made up for the U.S. All told, revenue rose 2.6%, profit from operations climbed 3.6%, and EPS grew 5.3%. In the current climate, I consider that a resilient result, and we remain on course to hit our full year guidance. I'm especially happy with how new categories performed, with revenue increasing by almost 27%, powered by solid volume and growth as well as pricing. Consumer numbers are up by more than 1.5 million year to date, and encouragingly, we're now extremely near breakeven. Because of that, we keep transforming quickly, and Non-Combustibles have already reached above 30% of revenue in 23 markets. That's close to 1/3 of the 71 markets where we're currently present in new categories. In many markets, our transformation has gone even further. As a share of revenue, Non-Combustibles already exceed 30% in France and surpass 50% in the U.K., led by Vuse. Above 50% in Japan, Poland, and Kazakhstan, led by glo. More than 70% of revenue in Sweden now comes from oral tobacco, thanks to our success with Velo. Notably, Sweden is on course to be the first smoke-free market in the EU, with smoking incidence nearing 5%.

Tadeu Marroco

executive
#3

Sweden has a long history of oral tobacco use, and its Modern Oral segment is expanding quickly — it stands as a strong illustration of how tobacco harm reduction can deliver real benefits. As you're aware, I've now spent 10 weeks in my new position. Over that period, my attention has gone to figuring out how we might tighten up how we execute. As an initial move, I announced last month the refreshed Management Board. Two key changes deserve highlighting. Johan takes on the Chief Operating Officer role, centered on delivering growth while being accountable for driving business performance, operational excellence, and best-in-class execution. Kingsley's new position, Chief Strategy and Growth Officer, is centered on enabling growth, with accountability for strategic development and a sharper consumer focus via an integrated approach to brands. This new structure backs my commitment to build an agile, modern, and progressive BAT, with a collaborative and inclusive culture, enabling simultaneous performance and transformation. As part of this, we must operate to the highest ethical standards, and this must remain a priority for both our employees and our business partners. Let me share some of what I've been doing during my first 10 weeks. One of my immediate priorities has been to visit a number of our key markets with my management team.

Tadeu Marroco

executive
#4

I have to say those visits have been humbling and reassuring in equal measure. BAT is a company with a great heritage. Our people and our brands have always been our two biggest assets. I have spent time with our people in these markets, and I have taken the time to listen. What is clear to me is that through the right enablers, our organization is ready. Our people are excited about the transformation journey ahead, with the opportunity to drive real change, both for BAT and society more broadly. I'm clear that BAT has a unique set of strengths and capabilities already in place. However, we can and must do better in order to evolve and accelerate our transformation. While my management team and I agreed that our multi-category strategy is right, we are also fully aligned on the areas that need greater focus, supported by a more collaborative and inclusive culture. Firstly, recognizing our diverse global footprint, we must set out the organizational focus and priorities in a clear way to ensure we execute flawlessly across all our markets. Sharpening execution is central to our market archetype model, enabling better resource allocation around fewer, bigger priorities that can be measured and for which the markets are accountable.

Tadeu Marroco

executive
#5

I realize this might come across as somewhat abstract, so let me make the model concrete through two markets, each standing for a distinct archetype. In Bangladesh, we've deliberately concentrated on keeping value share, revenue, and profitability growing in combustibles while we wait for clarity on how the new category will be regulated. In Poland, where new categories now account for more than 50% of our revenue, we keep expanding share, generating robust new category revenue growth and better contribution, together with value from our combustibles business. Each smoker we convert to our new category brands in Poland is margin creative for our business. That benefit gets amplified further because our market share in new categories is larger than in combustibles. These two markets show plainly where the model is working, through better decisions on resource allocation and strong results. We'll take these executional insights and ways of working and replicate them across our footprint. Second, we've achieved further improvement in new category contribution, cutting losses by GBP 200 million in the first half. Having made substantial investments in the base, new categories are now meaningfully contributing to Group results as we gain from greater scale. New categories are now profitable for us in 20 countries, which is more than double the count from the first half of last year.

Tadeu Marroco

executive
#6

I want to stress that we don't anticipate a straight-line path to profitability in new categories. We're deliberately choosing to keep putting money into our transformation, and the size of that investment mirrors our faster pace of innovation, our continued expansion into more geographies, and the openings we see in markets. Given how much progress we've made so far, I have confidence that we'll reach profitability in new categories in 2024. Vuse is a major contributor to our results, and that progress comes from our ongoing attention to three profitability levers: Revenue Growth Management, COGS reduction, and making marketing spend more effective. Vapour margins have traditionally been far below those of combustibles, THP, and Modern Oral, yet in recent years we've made considerable strides toward a commercially sustainable model with Vuse. At a Group level, our Vapour gross margin is quickly closing in on combustibles, and in the more established markets we're already generating a meaningful category contribution. I take pride in how much we're achieving, and I'm confident our transformation will produce long-term multi-category growth and returns. The third area I'm focused on is the critically important U.S. combustibles market. There, we're honing how we execute, thanks to new leadership and sharper focus, and by bringing commercial plans to life through our wide-ranging, digitally enabled Revenue Growth Management capabilities.

Tadeu Marroco

executive
#7

RGM is a flexible method for optimizing revenue, fueled by big data and analytics, and it gives us a detailed picture of elasticity curves. It unites our portfolio built around consumer occasions, pack price architecture, joint business planning with customers, optimized pricing, highly targeted trade activation, and assortment strategies tailored to each retailer — making sure our portfolio is well placed to meet competitive challenges and deliver profitable growth across all economic cycles. Early indicators of recovery in U.S. combustibles volume share are already emerging from our commercial plans. Since January, our volume share has risen 60 basis points, powered by a 100 basis points gain in the important premium segment. Encouraging as our progress is, we will keep executing our plans with care and thoughtfulness. Consequently, consistent combustibles value growth and returns will take time to achieve. Moving to my fourth focus area, THP, where I am determined to substantially strengthen what we offer consumers. To make that possible, we are broadening our capabilities by investing more in people and constructing new innovation hubs, among them our Global Device Development Center in China, to fuel a stronger innovation pipeline. As a top priority, we have already reengineered our internal innovation processes. Beyond that, we are building an agile innovation ecosystem via external partnerships, and by doing so, accelerating the pace of our transformation to drive better returns.

Tadeu Marroco

executive
#8

glo HYPER X2 Air, now in the process of launching, marks the initial move in a thrilling, speeded-up, medium-term pipeline for heated tobacco. Our 4D model makes this improved innovation pipeline process possible. We're strongly placed to draw on insights and foresights across categories, which means we define and prioritize consumer opportunities with precision. Through a focused discovery phase, we put those consumer understandings to work to validate the consumer proposition. We build the commercial offering at a quicker pace via our network of internal and external capabilities, and then finally we use our global scale and capability to deploy it fully. This dynamic model rests on our revamped product lifecycle capability and portfolio management discipline, which lets us adopt and adapt to economic conditions and competitive environments. All in all, this delivers better innovations and faster development, producing higher returns on investment. Leading responsible new category development is my next area of focus. I'm set on managing external risks in a thoughtful and transparent way by stepping up our engagement with regulators, policymakers, and relevant stakeholders, and by leveraging our science. With that in mind, we need a louder voice. We've now established a new Management Board role to drive more proactive corporate and regulatory affairs. Our activities will take a science-based approach to regulation to promote a level playing field in our markets.

Tadeu Marroco

executive
#9

Regulation poses a major obstacle to entering new categories. Navigating rules is familiar territory for BAT, but we now need to shift toward a more proactive outward stance that our science leads. My sixth area of focus, last but not least, is improving our financial flexibility. In the near term we have to be more nimble so we can make the right proactive decisions that create sustainable value over the long term. I want to be clear: our dedication to stepping up investment in our transformation will not be compromised. As I've laid out today, I'm equally clear about my priorities for the near term. To make BAT more agile and flexible, we'll draw on our worldwide portfolio to keep growing profit and cash, deliver GBP 1 billion in efficiencies across the coming three years to fund our transformation further, and cut debt to reinforce our balance sheet. Beyond that, we'll look for and assess ways to optimize how capital is allocated. Our free cash flow generation has risen substantially, with four years in a row of operating cash conversion of at least 100%. That has let us give shareholders a total of GBP 21 billion during this stretch, while leverage has also improved well. We stay committed to extending our 25-year record of consistent dividend growth, rewarding shareholders through every economic cycle.

Tadeu Marroco

executive
#10

Looking ahead to the coming five years, we expect to produce roughly GBP 40 billion in free cash flow before dividends. As our transformation keeps moving forward, the medium-term financial model we use for growth is going to change, and that gives us greater flexibility in how we deploy capital to drive returns and reward shareholders — returning cash in a sustainable way via dividends and share buybacks. With that, I'll pass things to Javed, who will walk you through the details of our results.

Javed Iqbal

executive
#11

Thank you, Tadeu, and good morning to all of you. Twenty-seven years ago, when I began my career at BAT as a Management Trainee in finance in Pakistan, I never imagined I'd have the chance to stand before you and present BAT's financial results in the role of Interim Finance Director. On a personal level, this is both a deeply humbling and a proud moment for me, but even more important, it stands as a strong testament to BAT's dedication to developing and growing an exceptionally diverse global talent pool. What drew me in most when I joined BAT was our international reach and the genuinely multicultural environment we work in, where each person has an equal chance to learn, to develop, and to advance their career. As a business leader, my focus is always on building a culture of respect and empowerment — or, to borrow Tadeu's phrasing, one that is inclusive and collaborative. That focus has supported a successful track record on my part of building high-performing teams and delivering commercial results that are both strong and sustainable. In my capacity as Interim Finance Director, I will work alongside Tadeu and the members of the Management Board to keep driving BAT's transformation journey forward. Among the areas that will receive my primary attention are resource allocation — drawing on tools such as marketing spend effectiveness and RGM — along with leveraging our digital hub capabilities and our Global Business Services footprint.

Javed Iqbal

executive
#12

We’ll keep putting money into technology and push our digital transformation further, so BAT becomes an organization connected digitally. Naturally, how we allocate capital and a sharper emphasis on generating cash will remain a top priority at all times. Now to the first half results. The results for the first half show continued delivery and the resilience of our business. Organic revenue growth came in at 2.8%, with new category revenue rising by nearly 27% and combustible price mix at 6%. Profit from operations rose 3.6%, while our operating margin was up 90 basis point at current FX and 40 basis point at constant FX, driven by the investment in new category contribution and our continuous focus on efficiencies. Diluted EPS increased by 5.3%, or 8.5% on a current currency basis. We keep driving strong new category revenue growth and are well on track to deliver on our GBP 5 billion revenue target by 2025. This was enabled by progressively building our consumer base together with capturing consumption moments and growing poly usage. Non-Combustibles now accounts for 16.6% of Group revenue, 1.8 percentage points higher than in 2022. I’ll now share more details on our key category drivers. Full market share across our key markets are available in the appendix.

Javed Iqbal

executive
#13

On Vapour, we grew our lead in value share, as Vuse hit 38.3% across the key vapour markets — a gain of 2.4 percentage points. Within the U.S., which is the biggest vapour market worldwide, Vuse reinforced its number one spot. Vuse share rose 5.7 percentage points, reaching 47% in track channels, and our confidence in the PMTA submission for Vuse Alto remains strong. We applaud the recent FDA moves concerning illicit synthetic nicotine disposables in the U.S. — a segment we estimate accounts for over 50% of the total vapour market — and we keep working with stakeholders to make sure unauthorized products get removed. In Canada, France, the U.K., and Germany, we held onto value share leadership in closed systems, while the modern disposable segment kept speeding up total category growth. That produced robust volume and revenue growth in AME. Beyond the U.S., we keep treating the modern disposable segment responsibly, with sustained dedication to preventing underage access, take-back schemes, and marketing practices. We're progressing well on improving profitability in Vapour, with a positive contribution in three of the five key markets, helped by greater scale and efficiencies in marketing spend. For Tobacco Heating, glo's reported revenues climbed 10%, or 12% on an organic basis.

Javed Iqbal

executive
#14

Turning to category volume share momentum in key AME markets, we saw continued gains in places like Poland and the Czech Republic, but those were offset by highly competitive conditions in Japan and Italy. Consequently, glo's share of THP category volume fell 110 basis points to 18.2%, even as our share of the combined combustible and THP category kept growing. As Tadeu pointed out, there's much more work ahead of us on strengthening our THP offering, but I'm pleased to report that glo HYPER X2 Air, our latest innovation, is showing positive early results. Our Modern Oral portfolio kept growing, with Velo volume rising 33% and revenue rising 42%, driven by geographic expansion and innovation. We continue to increase our volume share of total oral, while our volume share in the Modern Oral category was mainly affected by our ongoing prioritization of Vapour in the U.S. as we await the outcome of our PMTA submission for a new Velo product. Outside the U.S., we held onto leadership in the Modern Oral category, and I'm delighted to share that Velo is now the largest oral nicotine pouch brand in Sweden. We still see a significant opportunity for Modern Oral in emerging markets, with strong growth in Pakistan and a national rollout ahead of plan in Kenya.

Javed Iqbal

executive
#15

Now moving to combustibles. Volume fell 5.8%, driven largely by substantial excise hikes in Pakistan, weaker U.S. industry volume, and share loss stemming from our premium positioning. Cigarette price mix is still solid, rising 6%, with pricing largely offset by geographic mix. That produced a 0.2% gain in revenue. Group volume share rose 10 basis points, helped by gains in AME, with share steady in APMEA, partly offset by the U.S. Group value share fell 40 basis point as the effect of our commercial plans in the U.S. and losses in APMEA outweighed growth in AME. Outside the U.S., we are doing very well in combustibles, with a reinvigorated portfolio, refreshed brands, and sharper execution. This shows the value of our global footprint and our capacity to deliver in difficult environments. Moving to regions. In AME, total revenue rose 9%, lifted by higher combustible revenue, with resilient volume performance and a supportive pricing environment, offsetting some geographic mix headwinds. That comes alongside continued growth in each new category, with revenues up nearly 37%. Adjusted profit from operations rose nearly 8%, driven by better financial performance in key markets, among them Germany, Poland, Brazil, and Mexico.

Javed Iqbal

executive
#16

Looking at APMEA, total revenue rose almost 10%, powered by a strong combustible performance. That was led by pricing and by combustibles volume growth in Bangladesh, plus continued growth in every new category, where revenue climbed 15%. Adjusted profit from operations in APMEA increased 9%, helped by strong results in Australia and Sri Lanka and by further recovery in global travel retail. Turning to the U.S., combustible industry volume fell 8.4% during the first half. Beyond the market's secular decline, industry volume came under pressure from a mix of macroeconomic headwinds, which drove lower average daily consumption and downtrading, along with higher poly usage. Importantly, elasticities are holding steady at roughly 0.4. On top of those industry factors, our volume performance felt the effect of a lower volume share stemming from our more premium skewed portfolio, as we lapped the benefits of SAP-related inventory phasing in the comparator and the California flavor ban. That left our combustible volume down 12.4% in the U.S. As Tadeu highlighted, our commercial plans are beginning to show early signs of sequential volume share recovery. Supporting this, the industry premium segment is starting to stabilize, and our share of that premium segment has grown to its highest point in three years, driven by strengthening performance from Newport and Natural American Spirit.

Javed Iqbal

executive
#17

Lucky Strike is also doing well in the value segment, and it now holds over 3% of the total market. In Vapour, Vuse keeps strengthening its leading position, pushing revenue up 23%. Even with the tough environment, we've kept growing our operating margin by 280 basis points, thanks to Vuse profitability improving further and ongoing efficiency savings. In California, the long-term effects of the flavor ban are still unfolding. Menthol products are reportedly still being sold illegally because of weak enforcement, and we've also observed higher flavored volume in neighboring states, even though the industry has made its best effort to prevent that. Because of our menthol SKU, 45% of our portfolio had to be delisted in California at the end of last year. Our combustible volumes fell roughly 25% in H1, as many consumers shifted to our non-flavor variants, and our new FDA-authorized SKUs are doing well. After adjusting for a 13% pre-ban rate of decline, our underlying retention rate in California stemming from the flavor ban has come in above 85%. Vuse has delivered a very strong performance in California, with 100% retention, even though menthol accounted for 60% of volume before the ban. Fueled by the strength of our brand equity, Vuse has kept all of its pre-ban volume as consumers moved to our tobacco pods.

Javed Iqbal

executive
#18

In the tracks channel, Vuse picked up 8.7 percentage points of value share compared with before the ban. On the whole, nicotine consumption held roughly steady in H1, because the illicit modern disposable segment grew faster, with consumers still getting hold of illicit flavored nicotine product. Our view remains that there are more effective routes to tobacco harm reduction than limiting access to flavors. That can play an important role in encouraging adults to switch to reduced-risk products. At the same time, we will keep advocating for and supporting enforcement activities against illicit products, to help ensure that available products adhere to high consumer safety standards and support a level competitive playing field. Coming back to Group performance, operating margin expanded strongly, up 90 basis point at current rates and 40 basis point at constant rate. We absorbed headwinds of 2% from both increasing inflationary pressures and transactional effects on profit. This was supported by our strong progress improving new category profitability and additional efficiency savings. Moving now to EPS, we delivered constant currency adjusted diluted EPS growth of 5.3%. This reflects our resilient operating performance and the benefit of continued strong ITC delivery, which more than offset increased net finance cost and tax. Our cash flow conversion of 72% in the first half puts us well on track for another year of cash conversion in excess of 90%.

Javed Iqbal

executive
#19

Because of when leaf purchases and MSA payments fall, our cash flow is always weighted toward the second half. For the full year, we anticipated gross CapEx of GBP 550 million, which is below adjusted depreciation and amortization. We're still making solid progress on deleverage. As we guided earlier, our average cost of debt this year is 4.3%, well under current market rates, and we still expect higher rates to show up in our net finance cost in 2023 and going forward. We expect net finance cost for the full year to be around GBP 1.9 billion, subject to volatility in both FX and interest rates. Over the next five years, this business is on track to generate GBP 40 billion of free cash flows before dividends, with cash conversion above 90% and leverage heading toward the middle of our 2x-3x net debt to EBITDA corridor. That will give us greater business resilience while continuing to support future financial agility. As Tadeu outlined, we stay fully committed to investing further, executing better and delivering our strategy, while also rewarding shareholders throughout. We remain fully committed to our 65% dividend payout ratio over the long term, and to growth in sterling terms. Once we reach our leverage target, we'll review how to return cash to shareholders sustainably.

Javed Iqbal

executive
#20

So with that, I’ll turn things back over to Tadeu. Thank you.

Tadeu Marroco

executive
#21

Thanks, Javed. As we look ahead, we remain on course to meet our full year 2023 guidance. That is supported by robust growth in new categories, another decrease in new category losses, steady Combustible results, plus ongoing efficiency gains and solid cash generation. We anticipate organic revenue growth of 3%-5%, excluding Russia and Belarus, along with adjusted diluted mid-single figure EPS growth. This reflects added investment in new categories, sustained investment in U.S. combustibles, increased net finance costs, and a transactional FX headwind of roughly 2% — and all of this will hinge on when the transfer of our business in Russia and Belarus takes place. If we extrapolate current spot rates, currency translation should act as a 3% headwind to full year adjusted diluted EPS growth. To sum up, I am pleased with our resilient performance in the first half and the fresh energy I sense across the business, and I am confident that we are on track for our full year guidance. I take particular pride in our capacity to perform and transform at the same time, while consistently rewarding shareholders through rising cash returns. I am clear that much more remains to be done. Alongside my management team, we are energized to deliver on the focus areas we outlined today so we can accelerate our transformation.

Tadeu Marroco

executive
#22

I'd like to use this moment to express appreciation to all our colleagues across BAT for the steady backing they keep giving us and for producing these results. The possibilities in front of us excite me, and I have every confidence that over the long term we'll generate value for multiple stakeholders. Victoria will now come up on stage with us for the Q&A portion.

Victoria Buxton

executive
#23

Thanks, Tadeu, and good morning, everyone. If you're with us on the webcast, you can enter your questions straight into the online question box, or if you're on the call, just press star one on your telephone keypad. While we're waiting for questions to come up from the phone lines, Tadeu, I see we already have one for you. With your 30-year career at BAT and four years as Finance Director, what's going to be different now that you're Chief Executive?

Tadeu Marroco

executive
#24

Okay, to begin with, I want to say how honored I am to have been named chief executive. As you can see, and as I laid out in my presentation, BAT already possesses a great deal of one particular set of strengths. Ever since I stepped into the CEO role, I have been consistently clear that our strategy is the right one. We cannot ignore the fact that the world around us has shifted considerably. The environment in which we operate has grown far more complicated, the macroeconomic picture is far more difficult, and this demands sharper execution. One area I am focused on — a clear priority — is taking far more steps when it comes to allocating resources across geographies and across categories. That is why the market archetype is such a powerful example. I spoke to some of my key immediate priorities, which involve boosting our resilience in the U.S. combustible business from an economic cycle standpoint, but from a regulatory cycle standpoint as well. On innovations, we are beginning to change how we innovate across the Group. We intend to improve that substantially and then close the gaps we have around THP. And of course, return on investment will be a major focus for us going forward when we make those calls regarding execution.

Tadeu Marroco

executive
#25

The second leg has to do with. My wish is for the Group to become far more outward looking. There's a need for a more sustainable and engaging agenda with stakeholders, policyholders, regulators and policymakers, so that we can ensure an informative debate regarding the landscape in which we operate. That is referenced in the presentation. A level playing field has to be created. Many governments have plenty of desire to improve in certain elements of the new categories that we agree with. The question is for us to have the right discussion. I want to sharpen up the narrative of BAT and be much more outspoken out there, and, being on the, on the front foot means that I have created a new role in the Management Board, in corporate affairs, precisely to give me the backing to be able to do that and to, you know, articulate the whole organization towards that goal. Thirdly, it is about the culture. I genuinely have progressed with, you know, trying to promote a much more collaborative, inclusive culture, and that's what I want to see everywhere in BAT. I really believe that this can be very powerful, and I have read early signs that I think the vast majority of the BAT employees agree with me.

Tadeu Marroco

executive
#26

That would be the third area I'd focus on.

Victoria Buxton

executive
#27

Appreciate that, Tadeu. At this point we’ll open it up for questions from the phone lines, and I’ll hand things back to the operator.

Operator

operator
#28

Thanks. We'll take the question from Richard Felton at Goldman Sachs — go right ahead.

Richard Felton

analyst
#29

Thanks. Morning, everyone. My first question concerns the U.S. combustibles market. Now, you mentioned earlier today some initial signals of improvement in that business, yet it's still facing a fair amount of pressure. What I'd like to ask is this: you brought in new leadership for that business roughly a month ago. In your view, what will David do differently to drive better performance ahead in the U.S. combustibles business? My second question is also about the U.S., but it's on your Vapour business, where volume fell 6.5% during the first half. I'm certain you and the team aren't happy with that outcome. How are you thinking about bringing volume growth back for U.S. Vapour? And within that, I suppose, how do you weigh the trade-off between margin and volume growth specifically for that part of the business? Thank you.

Tadeu Marroco

executive
#30

All right, thanks, Richard. Honestly, I'm very enthusiastic about David joining Reynolds as its new CEO. He arrives with enormous expertise on the combustible side. For many years—4 or 5—he served as head of marketing, overseeing the Global Drive Brands, or GDBs, across the Group, before he moved on, and today he runs one of the crucial areas in Europe. While leading there, he managed to place us in a truly leading position in Vapour across the main European markets, and in Modern Oral as well. David offers a blend of experience that is fairly unique—not only in combustible but in new categories too—and his management style aligns closely with how I envision the company progressing. Having him on board excites me greatly, and I believe that alongside the Reynolds team he will deliver a fantastic job. As you noted, the U.S. situation is tough, since ultimately we faced secular decline and elasticity-driven normal declines that the macros made worse. The macro is essentially a mix of the incentives introduced at the federal and state levels, which were pulled back after post-COVID.

Tadeu Marroco

executive
#31

Meanwhile, significant inflationary strain has really squeezed how much consumers can spend. Since our business leans heavily toward the premium segment, we took the hardest hit. That is certain. Other factors also played into the drop in our volumes — a SAP rollout, for instance — yet fundamentally, we were tied to a segment that was under strain, reflecting the conditions we were dealing with in the U.S. On the bright side, we are now, for the first time, picking up early signals that the premium segment is stabilizing at the industry level, which is a real positive for us. Beyond that, the commercial plans we have rolled out are already beginning to bear fruit. The progress we have recorded is, you know, quite encouraging between January and today, when it comes to gains in our market share for Newport especially, and for Natural American Spirit too, for the premium segment overall and for the Group overall. Certainly, these economic cycles ebb and flow. What we aim to guarantee is that once this one wraps up, we emerge far stronger than when we entered it, and that is precisely the reason we are pursuing all of these commercial plans throughout our brands.

Tadeu Marroco

executive
#32

I believe David will be a strong addition for what we need to implement in the U.S. That's regarding David in the U.S. The U.S. Vapour market, you're absolutely right, is quite frustrating, honestly, to see the entire rise in these unauthorized products, synthetic nicotine products. We believe they are well ahead of 50% of the vapour markets today in the U.S., well ahead of that. What is, and this for sure, is putting pressure on overall consumption in the track channels. When you see the reduction of, as a group, as an industry, 15%, so BAT performed better, and then we had a reduction in 106. You see that this is just as a consequence of this exponential growth of this disposable nicotine device. If you add that to the mix, it's a completely different ballgame. You will be nowhere near the 15% reduction that we are seeing, because we are seeing a lot of traction of smokers actually using this type of products. What is encouraging is that the latest movements from the FDA in terms of trying to issue, for example, MDOs for some of those manufacturers, being very explicit that they are illicit products, even raising our penalty.

Tadeu Marroco

executive
#33

We will definitely be backing this FDA initiative. For each percentage point they can reduce, there is a huge white space. I'd say we're quite optimistic that this will materialize, since we know that many of the problems we have in Vapour when it comes to youth access stem naturally from the use of this type of product. I think there will be considerable mobilization from various agencies to tackle this problem in the U.S., and we'll be willing, you know, to see this happening.

Richard Felton

analyst
#34

Alright, thanks a lot.

Operator

operator
#35

Gaurav Jain from Barclays, the floor is yours.

Gaurav Jain

analyst
#36

Good morning, Tadeu, and good morning, Javed. I have three questions for you, if that's all right. First, regarding how you define leverage — I think many investors find it quite confusing. What exactly does the 2x-3x net debt to EBITDA figure mean? Is it based on the adjusted net debt and adjusted EBITDA as you report them? We have to make a number of adjustments, such as taking out Canada EBITDA and net cash, then adding restructuring charges, removing Russian net debt, and including hybrids. How should we read that 2x-3x corridor?

Tadeu Marroco

executive
#37

Do you want to handle this one?

Javed Iqbal

executive
#38

Yes. I believe that's the way we're reporting them at the moment. That's how they show up in our numbers, and we're heading toward the middle of the 2x-3x net debt to EBITDA corridor, as reported in our figures. As you can see, we've made solid progress from above 3x last year to reaching 2.6x now at the middle of the year. We're still on track to move toward that target. It's as reported in our number, without those adjustments.

Gaurav Jain

analyst
#39

Thanks.

Javed Iqbal

executive
#40

Yeah.

Gaurav Jain

analyst
#41

Apologies — please go ahead.

Javed Iqbal

executive
#42

No, let's move on to the second question.

Gaurav Jain

analyst
#43

Certainly. On the second question — regarding e-cigarette growth taking place in the U.S., with a large portion of the market shifting toward disposables, as you point out — in your view, counting disposables and all legal products, what was the growth of the U.S. e-cigarette market in 1H 2023 compared with 1H 2022?

Tadeu Marroco

executive
#44

Well, getting a complete picture or valuation in the U.S. is really tough, because as you know, the majority of these products go through channels that aren't tracked. They're independent shops—mainly vape stores, for instance. They're e-commerce; you can still purchase these products in the U.S. through e-commerce. It's really hard to form a view on that. Take, for instance, the estimate that the U.S. vapour market is worth roughly $5 billion—or, yeah, even a bit more than that—then the vast majority, as I mentioned, over 50%, ought by now to be clearly taken up by these products.

Gaurav Jain

analyst
#45

Thanks. On the third one, a quick question about the announced ITC Hotels spin-off — you'll hold roughly 18% or 19% of that spun-off entity.

Tadeu Marroco

executive
#46

Mm-hmm.

Gaurav Jain

analyst
#47

Do you plan to monetize that stake, or will you stay invested in that company?

Tadeu Marroco

executive
#48

Okay, Gaurav, so actually just yesterday we became aware of the ITC Board's decision to propose this structure — you know, spinning off and retaining 40% for the shareholders of the hotels, while giving the remaining 6% to the current shareholders. We'll have more details on that at the Board meeting scheduled for mid-August. At that point we're going to make a decision on it. As things progress, we'll make a call regarding what we, you know, choose to do — specifically once we've made that decision about this shareholding you're asking about.

Gaurav Jain

analyst
#49

Absolutely — thanks a lot.

Operator

operator
#50

Nik Oliver from UBS, you have the floor.

Nik Oliver

analyst
#51

Hey, thanks, Tadeu. I've got two questions. First, just one on the U.S. You mentioned the sequential improvement, and that's good to see. Looking ahead, do you still believe that a decline of 4%-5% remains the correct algorithm for the total U.S. market? Second, at the Group level. We're accustomed to modeling BAT as a company delivering high single-digit constant FX. Obviously, lately it's been lower, given the investments in NGPs and, you know, Ukraine, et cetera. Going forward, should high single-digit constant FX EPS still be the right algorithm?

Tadeu Marroco

executive
#52

All right, regarding the U.S., the question — the initial question was.

Javed Iqbal

executive
#53

What about industry volume?

Tadeu Marroco

executive
#54

So, industry volume and how it changes. In the U.S., definitely, the macro factors, as I mentioned, are cyclical in nature, right? What's favorable about the U.S. is that elasticity remains quite benign at 0.4, and one would expect that as the economy begins to recover, that macro component we highlighted in our presentation essentially disappears. That should return us to something like 5%. Now, whether it's higher — 4%-5%, 5%-6% — will hinge heavily on poly users going forward. I'd say right now there's nothing significant indicating we can't sustain that 5% level under normal conditions absent economic pressures, since elasticity is still quite benign, as I said, meaning substantial pricing power remains in the U.S. The secular piece plus elasticity will likely get you to that level, roughly around there, depending on the poly usage phenomenon we observe going forward. Regarding the future of financial algorithm, the future for the Group — what we're confronting is very challenging times, because we — and this was among the reasons we emphasized it in today's presentation.

Tadeu Marroco

executive
#55

Today, our net finance costs sit considerably below the level the market is currently showing. We have all these maturities arriving over the next several years, and that is going to translate into increased net finance costs. It really is that straightforward. What that means is the kickers on EPS won't be counted on net finance cost. If anything, it will likely act as a drag. Those are factors I must factor in when you begin discussing, you know, a short-term, high single digit kind of figure. Another short-term item we should keep in mind is that although macroeconomic pressures have eased considerably, a significant impact is still coming next year on the back of leaf. The reason is that a portion of the leaf costs we are seeing this year will mostly affect next year's P&L, given their nature. They move off your balance sheet and only begin hitting your P&L months afterward. We will have to confront that pressure. As I also mentioned in my presentation, we do not expect the fix in the U.S. that we want to make in combustible to be a quick one.

Tadeu Marroco

executive
#56

This is going to take a while, and we'll handle it the right way, since our goal is building a portfolio that's more resilient so it can deliver sustainable value across time. Having said that, we can't, you know, overlook the reality that we're a company generating enormous amounts of cash. BAT is performing exceptionally well in new categories. We're cutting the loss at a greatly accelerated rate, which is why we've said this won't be linear, since it will depend heavily on our plans for geographic expansion, which markets can open, and the new platforms we launch. One thing stands out clearly, the direction we're heading is very clear. This will be accretive to the Group's results, it has been since 2021, and nothing stands in the way of us continuing on that path going forward. Our combustible business outside the U.S. is doing extremely well. Despite all the difficulties in the U.S., our price mix remains at 6%. We have a very, very, very strong company in our hands as we move forward. What we're trying to show all of you today is just how resilient this company is. We are facing, you know, difficult times in the combustible business, in the U.S.

Tadeu Marroco

executive
#57

To be specific — and the results we're currently seeing in the categories outside combustible, plus in the other geographies, more than make up for it — once all of those pieces line up, we'll be in a far stronger position. I hope that gives you a sense of the picture. I don't want to make short-term commitments on this, and we know exactly where we stand in the short term, but the future matters when it comes to giving you some prospect going forward.

Nik Oliver

analyst
#58

Oh, no, that’s really clear. Thanks, Tadeu. That was great.

Operator

operator
#59

Jacob de Klerk from Redburn, you have the floor.

Jacob de Klerk

analyst
#60

Hi, Tadeu — thanks for taking my question, and I appreciate the extra details. I’ve got a couple of questions about how your new category is performing. Looking at the whole traditional oral segment in the U.S., not only BAT’s brand portfolio, it looks like growth in Modern Oral nicotine pouches is weighing on it. Is that a fair way to characterize the overall U.S. oral market, and do you expect that trend to keep going? And second, revenue across all three new categories is rising strongly. Could you give us some sense of how that’s playing out? Is most of it coming from launches in new markets — for example, Modern Oral doing well in Pakistan — or are established markets like Vapour in the U.S. driving the bulk of it?

Tadeu Marroco

executive
#61

So Modern Oral in the U.S. is doing what we see in other traditional oral markets around the world, such as Sweden and Norway. We're seeing Modern Oral pick up momentum when it comes to total oral consumption. The difference is that average daily consumption in the U.S. is really low. It's between one to two pouches, versus, you know, six, seven pouches that you see in the Nordics, for example. That comes down to the product itself. The product has a moisture level that isn't really satisfying consumers the way we can see outside. One of the difficulties we have as BAT with our own offer in the U.S. is the fact that we couldn't bring this product that we have in Europe, this excellent and leading product that we have in Europe, to the U.S. yet. We have applied for PMTA. We are waiting for the outcome of the of the PMTA, in order to be able to launch this product in the market. I think that once these type of products reach the U.S., we will see a bigger traction, let's put it that way, in that particular market.

Tadeu Marroco

executive
#62

This is certainly a key area we're focused on, and we feel really good about what we can offer outside the U.S. once we're able to bring it into the U.S. market itself. That's one point. To address your question, beginning with Modern Oral, the performance here has been fantastic. We've got a fantastic product on our hands. We've just hit an all-time high in leadership when it comes to share in Sweden, and as you know, Sweden has been dominated by our competitor for over 100 years — it's a very traditional oral market. In terms of share, Velo took the lead across the whole oral tobacco segment in Sweden — not just Modern Oral. Wherever we operate, this leadership has been reflected. We're leading in several markets. Another thing we're noticing is that even in markets without a traditional oral category, this product is gaining traction. Take the U.K., for example — there was no tradition at all there, and the incidence of Modern Oral is already approaching 2%; it was 1.5%, and now it's picking up traction. We're seeing this phenomenon occur in other markets too. In Poland, for instance, we launched this product about two years ago, and now our volumes are really, you know, reaching a significant level.

Tadeu Marroco

executive
#63

What's great about these items is that the margins, as you likely noticed in my presentation, actually exceed those on cigarettes. This product doesn't even contain tobacco, so its risk profile is quite low, and it can serve as a means of implementing tobacco harm reduction, much like what we observe in Sweden. Sweden once had a combustible incidence of 30% back in the 1970s. Today, as I mentioned in my presentation, it's on the verge of becoming the first smoke-free market in the EU, driven by the promotion of traditional oral, with cancer incidence falling dramatically over that stretch of time. The margins we earn on oral are greater than those we earn on cigarettes. This benefits everyone involved, and that is precisely the model — the potent model — that we possess. Modern Oral reflects our geographic expansion combined with continued strong performance in the markets we've already established. On Vapour, we have, you know, rolled out our Vuse Go, our modern disposable. We chose to enter this subcategory since we clearly observe many smokers moving toward this kind of product. For Vapour, the rate at which cigarette smokers convert to vapour resembles THP, and in fact, in markets where vape and THP both exist, we witness greater retention in vapour than we do in THP, in markets where both are present.

Tadeu Marroco

executive
#64

This category is picking up more and more momentum. I'm really happy with how we're doing on margins. That margin improvement comes thanks to scale, certainly, but also because we now have a leading brand and can go back and renegotiate trade margins — cutting them, for instance — and also take price. The revenue gain you're seeing results from expansion, but equally from our work on the vapour margin side, which is now approaching 6%. There are markets already, France for example, where, if you look at the gross margin equivalent per mil of cigarettes, we earn more from selling Vuse than from selling our own cigarette products in France. In the U.S., our margins are already on par with Pall Mall in cigarettes. We're really, really pleased with how we're performing there. THP is the category where we're flagging one area of focus for us, in the sense that our offers need strengthening. I'd say the glo HYPER X2 is heading in the right direction. Is it a game changer? No, it isn't a game changer. It's an improvement, because it tackles some of the issues, or pain points, that our offer had — with a sleeker, tinier, and, you know, a very light device.

Tadeu Marroco

executive
#65

We’ve got some more exciting ideas that are on the way over the next few months. All right?

Jacob de Klerk

analyst
#66

Thanks so much.

Operator

operator
#67

Jonathan Leinster at Société Générale, the floor is yours.

Jon Leinster

analyst
#68

Oh, hello. Good morning, gentlemen. Yes, I have a couple or a few questions, if I may. First of all, in light of the recent nationalization of some companies that had been planning to transfer assets in Russia, has that altered your plans in any way regarding your potential transfer in Russia?

Tadeu Marroco

executive
#69

Alright. Alright, Jonathan, I'll take this one. Look, our determination to exit the country is firm. We stated that last year. As you can imagine, dealing with this is a very, very complicated situation, and we are complying with every international and local law, and that means all the procedures that the local authorities in Russia have laid out, and with close attention to sanctions, of course. I'm not able to say much about that right now. Making further comments on that would be inappropriate for me.

Jon Leinster

analyst
#70

All right, thank you. And then second, regarding U.S. cigarettes, price mix has obviously slowed somewhat. Is that mostly because of how pricing is structured, or does it come from the mix moving toward Lucky Strike, or is it some combination of both?

Tadeu Marroco

executive
#71

Right, so we're rolling out commercial plans across the U.S. Revenue Growth Management is another area we're leaning on for insights, which lets us get really granular about making our brand more competitive across different geographies in the U.S. Not just that — we can drill all the way down to councils or key accounts and so on. The pricing piece you're seeing reflects those commercial plans being in place. We're also running some initiatives to ladder certain brands, making them more resilient through these economic cycles. All of that shows up in the top line you're seeing.

Jon Leinster

analyst
#72

Did Lucky Strike grow in that kind of pseudo-discount way?

Tadeu Marroco

executive
#73

Yeah.

Jon Leinster

analyst
#74

Does that have a pretty big impact on it?

Tadeu Marroco

executive
#75

Sure, that's part of it, I'd say. With Lucky Strike, we're really happy with how it's performing — it's one of the most successful launches ever in the U.S. It has just gone past 3% of total market share in the U.S. Of course, the mix in Luck will be quite different from what you see with Newport and Natural American Spirit. I'd say most of the price impact comes from the commercial plans we're putting in place to boost our competitiveness in the more important premium segments — that's where we were hurting the most.

Jon Leinster

analyst
#76

Okay, so on vaping again, price mix was really strong in the period. Is that, as we hear it, a reflection again of genuinely strong underlying price, especially in Europe and some of the other regions? Or is it simply the difference in mix, with the introduction of the disposables? Has that made price mix appear to shift up quickly as those disposable vapes came in?

Tadeu Marroco

executive
#77

Jonathan, every pricing choice for vapour in the U.S. is made with several factors in mind. Our Revenue Growth Manager approach is applied to vapour as well. To illustrate, we take into account the price of modest — which, by the way, isn't cheap in the U.S. We factor in cigarette prices, and we also look at what our biggest competitor charges in tracked channels. Another element is that our pod holds over twice the liquid of our main second competitor's product in the U.S. All of these go into the analysis, along with elasticities, so we understand consumers. We've been developing various product architectures when it comes to packs — one pod, two pods, four pods, and more recently even more than that, such as six pods. With all of this, you get the consolidated price mix picture that shows up in our results. There's no single element to single out; rather, it's a combination of all these different pieces.

Jon Leinster

analyst
#78

I.

Tadeu Marroco

executive
#79

We will definitely be keeping this under review, you know, and we're taking immediate actions on that.

Javed Iqbal

executive
#80

And in my case, if I may.

Jon Leinster

analyst
#81

Honestly, I was genuinely much more focused on markets beyond America—outside the U.S., the USA, truly.

Javed Iqbal

executive
#82

Alright.

Jon Leinster

analyst
#83

So that's the market where you introduced the disposable vapes. I was simply asking whether that represents, of course, a fairly significant change in the mix and a greater value in those regions where disposable vapes have been introduced, clearly beyond the USA.

Javed Iqbal

executive
#84

That's the point I was trying to add — Vuse as a brand is performing strongly, and that's why revenue growth from pricing comes from both elements: the Vuse closed system and Vuse Go, which is the disposable part of the brand. For the brand overall, pricing is being driven positively, mainly by both of those elements.

Tadeu Marroco

executive
#85

When we look beyond the U.S.,

Javed Iqbal

executive
#86

Turning to markets beyond America — that's the reason I wanted to address the international point. Outside America, we continue to observe robust pricing growth, and the main driver there is the powerful brand momentum, both in the closed systems and in the launch and rollout of Vuse Go.

Jon Leinster

analyst
#87

All right, thanks a lot.

Operator

operator
#88

Thank you. With that, I'd like to return the call to Victoria so she can take any questions from the web.

Victoria Buxton

executive
#89

Thanks. We’ll return to the web now, since a question has come in there. I believe this one is directed at you, Javed. Your combustible volumes fell 5.7% while the industry declined 3.2%. What explains BAT trailing the industry?

Javed Iqbal

executive
#90

I think this one's pretty straightforward — there are two points. First, the biggest impact comes from the excise-driven price hikes in Pakistan, so that's an excise-driven volume decline there, plus the overall industry decline in the U.S. Take Pakistan alone, for instance: if you strip Pakistan out of the industry and BAT volumes, we'd be looking at a 2% volume decline, and that's where BAT actually starts doing better. Because of our very strong presence in Pakistan, that's why you're seeing such a strong decline. Those are the two elements — the rest is very minor changes. Those are the two things: excise-driven volume in Pakistan, and also the overall industry decline in the U.S.

Tadeu Marroco

executive
#91

I think that's an important point, just to build on what Javed said — we aren't adjusting our volumes to fit the markets where we still are; we're phasing out. Take Egypt, for instance, which is still included in that. If you consider that, say, it will be grouped with Russia, which, you know, we basically don't manage, then this would be 1% out of the 5.7%. What remains is essentially what Javed described for those two markets. Yeah.

Victoria Buxton

executive
#92

Thanks. Well, it looks like there aren’t any more questions coming in on the web. If anyone still has questions, please feel free to reach out to the IR team. With that, I’ll now turn things back to Tadeu for the closing remarks.

Tadeu Marroco

executive
#93

Alright. Thanks for being here today and for taking part in our Q&A. As you can see, we've turned in a resilient performance for the first half. I'm delighted that we remain on track for our full year guidance, and I hope all of you can see the renewed sense of energy across the organization, which I feel around me every day. There is much more to do, but I'm confident that together, we will accelerate our transformation and deliver long-term multi-stakeholder value. We look forward to updating you again in December at our pre-close trading update. Thank you very much!

Read the full transcript via the API

You're viewing the first half of this call. Get the complete British American Tobacco p.l.c. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to British American Tobacco p.l.c. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in British American Tobacco p.l.c. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.